top of page
Our Circular mRNA
Our proprietary circular mRNA platform, patented pending # PCT/TH2023/000003, provides better performances than the existing linear mRNA platform. The advantages of circular mRNA can be described as followed;
1
2
3
4
5
More stability than Linear mRNA:
Better efficacy and storage condition
Higher performance: Lower dose and cost saving.
Faster design
& easy production:
For new emerging disease vaccine.
No synthesis substance in products:
Reduce inflammation and side-effect.
Own I.P.
& inimitability:
Freedom to operate and enable licensing.
Publications & References
bottom of page